Applied DNA Sciences manufactures linear deoxyribonucleic acid (DNA) for use in its proprietary products as well as for sale to third parties. Co. manufactures non-biological DNA-based molecular taggants for use in its proprietary supply chain security, anticounterfeiting, brand protection and law enforcement products. Through its subsidiary, LineaRx, Inc., Co. supplies polymerase chain reaction produced linear DNA for use in preclinical biotherapeutic applications including CAR T/TCR, RNA manufacture, DNA-based vaccines and gene therapies, as well as in vitro diagnostics. We show 27 historical shares outstanding datapoints in our APDN shares outstanding history coverage, used to compute APDN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing APDN market cap history over the course of time is important for investors
interested in comparing APDN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of APDN versus a peer is one thing; comparing
APDN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like APDN can fluctuate over the course of history.
With this page we aim to empower investors researching APDN by allowing them to research the APDN market cap history. |
Video: The Importance of Market Cap
